FDA Inspection
Western Kentucky Regional Blood CtrWestern Kentucky Regional Blood Ctr – FDA Inspection, Apr 23, 2025
Record Details
This FDA Inspection record concerns Western Kentucky Regional Blood Ctr, with an inspection on April 23, 2025, issued by the Cincinnati District Office, covering biologics.
View Company Profile
ID · a1bace17-08ea-4704-a061-ec9df2682e08
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1267663
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 606.171Biological product deviation report
- 21 CFR 606.160(a)(1)Concurrent documentation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Western Kentucky Regional Blood Ctr
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 18, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 29, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 24, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 28, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 9, 2012 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Western Kentucky Regional Blood Ctr
- FDA Inspection 1219654 - 2023-08-18
- FDA Inspection 1059016 - 2018-06-29
- FDA Inspection 963590 - 2016-03-24
- FDA Inspection 869875 - 2014-02-28
- FDA Inspection 772051 - 2012-03-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.